Related Experiment Video
Updated: Aug 7, 2026
07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Modeling rare melanoma subtypes: mechanisms, microenvironments and translational opportunities
Qingxue Meng1, Fengxu Yan2, Chenchen You2
1Hebei Key Laboratory of Systems Biology and Gene Regulation, Technology Department, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, China.
Frontiers in Oncology
|August 6, 2026
Summary
This review explores animal models for rare melanoma subtypes, like uveal and acral melanoma. Understanding these models is crucial for developing new therapies for these challenging cancers.
Area of Science:
- Oncology
- Translational Research
- Animal Models
Background:
- Rare melanoma subtypes (uveal, desmoplastic, mucosal, acral) comprise ~10% of melanomas.
- These subtypes present unique genetic profiles and immune microenvironments, often resulting in poor prognosis.
- Limited clinical samples and low incidence hinder research and therapeutic development for rare melanomas.
Purpose of the Study:
- To review and analyze current animal models utilized for studying rare melanoma subtypes.
- To evaluate the advantages and limitations of various models in preclinical research.
- To identify future directions for enhancing animal models to facilitate mechanistic studies and precision therapies.
Main Methods:
- Review of existing literature on animal models for rare melanoma.
- Categorization of models into spontaneous, inducible, genetically engineered, and xenograft types.
- Analysis of model fidelity in simulating genetic backgrounds and immune microenvironments.
Main Results:
- Various animal models exist, each with specific strengths and weaknesses.
- Limitations include genetic accuracy, microenvironment simulation fidelity, and applicability to immunotherapy research.
- Current models offer valuable insights but require further refinement for comprehensive preclinical evaluation.
Conclusions:
- No single animal model perfectly recapitulates all aspects of rare melanomas.
- Advancements in multi-dimensional simulation of genetics and microenvironment are needed.
- Improved animal models are essential for advancing mechanistic understanding and developing targeted therapies for rare melanoma subtypes.
